These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29423673)
1. Stromal expression of JNK1 and VDR is associated with the prognosis of esophageal squamous cell carcinoma. Bao Y; Zhang S; Guo Y; Wei X; Zhang Y; Yang Y; Zhang H; Ma M; Yang W Clin Transl Oncol; 2018 Sep; 20(9):1185-1195. PubMed ID: 29423673 [TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
3. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
4. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
5. Nicotinic cholinergic receptors in esophagus: Early alteration during carcinogenesis and prognostic value. Chianello Nicolau M; Pinto LF; Nicolau-Neto P; de Pinho PR; Rossini A; de Almeida Simão T; Soares Lima SC World J Gastroenterol; 2016 Aug; 22(31):7146-56. PubMed ID: 27610024 [TBL] [Abstract][Full Text] [Related]
6. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer. Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532 [TBL] [Abstract][Full Text] [Related]
7. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F. Yang H; Wei YN; Zhou J; Hao TT; Liu XL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965 [TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation. Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721 [TBL] [Abstract][Full Text] [Related]
9. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141 [TBL] [Abstract][Full Text] [Related]
10. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma. Liu L; Yang Z; Ni W; Xuan Y Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036 [TBL] [Abstract][Full Text] [Related]
11. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38α- and JNK-mediated apoptosis in esophageal squamous cell carcinoma. Liu J; Lv L; Gong J; Tan Y; Zhu Y; Dai Y; Pan X; Huen MSY; Li B; Tsao SW; Huo J; Cheung ALM Int J Cancer; 2018 Jan; 142(1):145-155. PubMed ID: 28905993 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
16. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo. Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167 [TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945 [TBL] [Abstract][Full Text] [Related]
18. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143 [TBL] [Abstract][Full Text] [Related]
19. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis. Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810 [TBL] [Abstract][Full Text] [Related]
20. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway. Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]